Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31x
Symbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through a fresh issue and offer for sale. Anchor investors contributed Rs 526.20 crore before the public issue opened.
The Economic Times ·